To assay the effect of inflammatory E-cadherin + DCs on the T cell response and antitumour activity in vivo, we transferred 5 × 105 E-cadherin + DCs loaded with the CEA526-533 peptide into an orthotopic lung tumour model by tail-vein injection on days 7, 14, and 21 following tumour establishment. This evidence concerns the gene CDH1 and neoplasm.